Preparation of <sup>124</sup>I, Antibody Labeling and Micro-PET/CT Imaging of Labeled Compounds

HOU Xingguo; WANG Feng; DING Jin; ZHU Hua; YANG Zhi

doi:10.7538/tws.2023.youxian.101

Journal of Isotopes > 2024 > 37(4): 387-393. > DOI: 10.7538/tws.2023.youxian.101

HOU Xingguo, WANG Feng, DING Jin, ZHU Hua, YANG Zhi. Preparation of ¹²⁴I, Antibody Labeling and Micro-PET/CT Imaging of Labeled Compounds[J]. Journal of Isotopes, 2024, 37(4): 387-393. DOI: 10.7538/tws.2023.youxian.101

Citation:

PDF (1233 KB)

Preparation of ¹²⁴I, Antibody Labeling and Micro-PET/CT Imaging of Labeled Compounds

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China

More Information

Received Date: November 20, 2023
Revised Date: March 11, 2024

Graphical Abstract

Abstract

Abstract

To provide a method for the production of ¹²⁴I by using a medical cyclotron and the method of ¹²⁴I labeling, ¹²⁴I was prepared using a nuclear reaction of ¹²⁴Te (p, n) ¹²⁴I. Firstly, a ¹²⁴TeO₂/Al₂O₃ target was obtained by pressing, and then bombarded with a cyclotron for 3-8 hours. After 12 hours, impurity nuclides produced by the side reaction were removed. Finally, a Na¹²⁴I solution was obtained by iodine sublimation radiochemical separation method. Analyze the purity of Na¹²⁴I and label it with anti-mesothelin (MSLN) antibody, then inject it into the tail vein of KM mice to observe the distribution of ¹²⁴I-anti-MSLN. The obtained ¹²⁴TeO₂/Al₂O₃ target was bombarded with 12.5 MeV energy and 20 μA proton beam to obtain 340.4-1121.1 MBq nuclide products, and after purification, 274.2-758.5 MBq of high-purity Na¹²⁴I solution was obtained. The final radioactive concentration of the obtained Na¹²⁴I solution was greater than 54840 Bq/μL. Using the Na¹²⁴I solution to label an anti-MSLN antibody, ¹²⁴I-anti-MSLN probe with a radiochemical purity greater than 99% was obtained. The probe was injected into KM mice via the tail vein, and significant uptake of the probe was observed in the thyroid region of the mice through Micro-PET/CT imaging. This uptake can be blocked by feeding 0.5% KI solution 3 days in advance, and the metabolic behavior conforms to the metabolic pattern of the ¹²⁴I labeled antibody probe in KM mice. This study summarized the purification of ¹²⁴I samples of 25 batches in our unit, and tthe equipment and methods involved in the purification process and the use of Na¹²⁴I after purification were summarized. In order to provide reference for the production and efficient purification of ¹²⁴I. The results showed that the purified ¹²⁴I had high nuclear purity and chemical purity, which met the requirements of radiolabeling. The average recovery rate was higher than 70%, and the automatic purification process was safe and reliable.
- solid target radionuclide,
- iodine-124,
- tellurium-124 solid target,
- ¹²⁴I auto-purification system,
- Micro-PET/CT

FullText(HTML)

References (26)

References

[1]	Wadas T J,Wong E H,Weisman G R,et al. Coordinating radiometals of copper,gallium,indium,yttrium,and zirconium for PET and SPECT imaging of disease[J]. Chemical Reviews,2010,110(5):2858-2902. doi: 10.1021/cr900325h
[2]	Wei W,Rosenkrans Z T,Liu J,et al. ImmunoPET:Concept,design,and applications[J]. Chemical Reviews,2020,120(8):3787-3851. doi: 10.1021/acs.chemrev.9b00738
[3]	Verel I,Visser G W M,van Dongen G A. The promise of immuno-PET in radioimmunotherapy[J]. Journal of Nuclear Medicine,2005,46(Suppl 1):164S-171S.
[4]	Wilson C B,Snook D E,Dhokia B,et al. Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer[J]. International Journal of Cancer,1991,47(3):344-347. doi: 10.1002/ijc.2910470305
[5]	Holland J P,Williamson M J,Lewis J S. Unconventional nuclides for radiopharmaceuticals[J]. Molecular Imaging,2010,9(1):1-20.
[6]	Guenther I,Wyer L,Knust E J,et al. Radiosynthesis and quality assurance of 5-[¹²⁴I]Iodo-2'-deoxyuridine for functional PET imaging of cell proliferation[J]. Nuclear Medicine and Biology,1998,25(4):359-365. doi: 10.1016/S0969-8051(97)00220-5
[7]	Pandey S K,Gryshuk A L,Sajjad M,et al. Multimodality agents for tumor imaging (PET,fluorescence) and photodynamic therapy. a possible “see and treat” approach[J]. Journal of Medicinal Chemistry,2005,48(20):6286-6295. doi: 10.1021/jm050427m
[8]	Cheng Y,Shi D,Ye R,et al. Noninvasive evaluation of PD-L1 expression in non-small cell lung cancer by immunoPET imaging using an acylating agent–modified antibody fragment[J]. European Journal of Nuclear Medicine and Molecular Imaging,2023,50(6):1585-1596. doi: 10.1007/s00259-023-06130-6
[9]	Hou X,Wang F,Meng X,et al. Construction of a ¹²⁴I-labeled specific antibody for the noninvasive detection of mesothelin-overexpressing tumors[J]. Molecular Pharmaceutics,2022,19(10):3623-3631. doi: 10.1021/acs.molpharmaceut.2c00342
[10]	Li D,Ding J,Liu T L,et al. SARS-CoV-2 receptor binding domain radio-probe:a non-invasive approach for angiotensin-converting enzyme 2 mapping in mice[J]. Acta Pharmacologica Sinica,2022,43:1749-1757. doi: 10.1038/s41401-021-00809-y
[11]	Yao Y,Hou X,Liu S,et al. Construction and preclinical evaluation of a ^124/125I-labeled specific antibody targeting PD-L2 in lung cancer[J]. Molecular Pharmaceutics,2023,20(2):1365-1374. doi: 10.1021/acs.molpharmaceut.2c00958
[12]	Schmitz J. The production of [¹²⁴I]iodine and [⁸⁶Y]_y ttrium[J]. European Journal of Nuclear Medicine and Molecular Imaging,2011,38(1):4-9.
[13]	Nagatsu K,Fukada M,Minegishi K,et al. Fully automated production of iodine-124 using a vertical beam[J]. Applied Radiation and Isotopes,2011,69(1):146-157. doi: 10.1016/j.apradiso.2010.09.010
[14]	Qaim S M,Hohn A,Bastian T,et al. Some optimisation studies relevant to the production of high-purity ¹²⁴I and ^120gI at a small-sized cyclotron[J]. Applied Radiation and Isotopes,2003,58(1):69-78.
[15]	Sajjad M,Bars E,Nabi H A. Optimization of ¹²⁴I production via ¹²⁴Te(p,n)¹²⁴I reaction[J]. Applied Radiation and Isotopes,2006,64(9):965-970.
[16]	Kondo K,Lambrecht R M,Norton E F,et al. Cyclotron isotopes and radiopharmaceuticals—XXII. Improved targetry and radiochemistry for production of ¹²³I and ¹²⁴I[J]. Applied Radiation and Isotopes,1977,28(9):765-771. doi: 10.1016/0020-708X(77)90107-7
[17]	Bastian T,Coenen H H,Qaim S M. Excitation functions of ¹²⁴Te(d,xn)^124,125I reactions from threshold up to 14 MeV:Comparative evaluation of nuclear routes for the production of ¹²⁴I[J]. Applied Radiation and Isotopes,2001,55(3):303-308. doi: 10.1016/S0969-8043(01)00079-3
[18]	Van Den Bosch R,De Goeij J J M,Van Der Heide J A,et al. A new approach to target chemistry for the iodine-123 production via the ¹²⁴Te(p,2n) reaction[J]. Applied Radiation and Isotopes,1977,28(3):255-261. doi: 10.1016/0020-708X(77)90071-0
[19]	Hassan K F,Qaim S M,Saleh Z A,et al. 3He-particle-induced reactions on natSb for production of ¹²⁴I[J]. Applied Radiation and Isotopes,2006,64(4):409-413. doi: 10.1016/j.apradiso.2005.08.013
[20]	Uddin M S,Hermanne A,Sudár S,et al. Excitation functions of α-particle induced reactions on enriched ¹²³Sb and natSb for production of ¹²⁴I[J]. Applied Radiation and Isotopes,2011,69(4):699-704. doi: 10.1016/j.apradiso.2010.12.007
[21]	Kumar K,Ghosh A. Radiochemistry,production processes,labeling methods,and ImmunoPET imaging pharmaceuticals of iodine-124[J]. Molecules,2021,26(2):414. doi: 10.3390/molecules26020414
[22]	Koehler L,Gagnon K,McQuarrie S,et al. Iodine-124:a promising positron emitter for organic PET chemistry[J]. Molecules,2010,15(4):2686-2718. doi: 10.3390/molecules15042686
[23]	Cascini G L,Niccoli Asabella A,Notaristefano A,et al. 124 Iodine:A longer-life positron emitter isotope-new opportunities in molecular imaging[J]. BioMed Research International,2014,2014:672094.
[24]	李立强,王风,刘特立,等. 碘-124的生产、标记及在肿瘤PET分子影像的应用[J]. 同位素,2018,31(3):188-197. doi: 10.7538/tws.2018.31.03.0188 Li Liqiang,Wang Feng,Liu Teli,et al. Production of iodine-124 and its application in PET molecular imaging[J]. Journal of Isotopes,2018,31(3):188-197 (in Chinese). doi: 10.7538/tws.2018.31.03.0188
[25]	朱华,王风,郭晓轶,等. 固体靶PET核素碘-124的制备、质控及甲状腺分子显像[J]. 北京大学学报(医学版),2018,50(2):364-367. doi: 10.3969/j.issn.1671-167X.2018.02.027 Zhu Hua,Wang Feng,Guo Xiaoyi,et al. Preparation,quality control and thyroid molecule imaging of solid-target based radionuclide ioine-124[J]. Journal of Peking University (Health Sciences),2018,50(2):364-367 (in Chinese). doi: 10.3969/j.issn.1671-167X.2018.02.027
[26]	Lamparter D,Hallmann B,Hänscheid H,et al. Improved small scale production of iodine-124 for radiolabeling and clinical applications[J]. Applied Radiation and Isotopes,2018,140:24-28.